PTRH2 and neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset 1: The study of PTRH2 loss of function mutations in IMNEPD patients and in a global knockout mouse has revealed its essential roles in the regulation of pro-survival and anoikis signaling in addition to cellular stress responses, cell size, and myoblast differentiation.